These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 27933352)

  • 1. Intracochlear drug delivery in combination with cochlear implants : Current aspects.
    Plontke SK; Götze G; Rahne T; Liebau A
    HNO; 2017 Jan; 65(Suppl 1):19-28. PubMed ID: 27933352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intracochlear drug delivery in combination with cochlear implants : Current aspects].
    Plontke SK; Götze G; Rahne T; Liebau A
    HNO; 2016 Nov; 64(11):797-807. PubMed ID: 27757480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microimaging of a novel intracochlear drug delivery device in combination with cochlear implants in the human inner ear.
    Lehner E; Menzel M; Gündel D; Plontke SK; Mäder K; Klehm J; Kielstein H; Liebau A
    Drug Deliv Transl Res; 2022 Jan; 12(1):257-266. PubMed ID: 33543398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in local drug delivery to the inner ear.
    El Kechai N; Agnely F; Mamelle E; Nguyen Y; Ferrary E; Bochot A
    Int J Pharm; 2015 Oct; 494(1):83-101. PubMed ID: 26260230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State-of-the-art methods in clinical intracochlear drug delivery.
    Chin OY; Diaz RC
    Curr Opin Otolaryngol Head Neck Surg; 2019 Oct; 27(5):381-386. PubMed ID: 31460985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological Issues in Hearing Rehabilitation.
    Bird PA; Bergin MJ
    Adv Otorhinolaryngol; 2018; 81():114-122. PubMed ID: 29794456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cochlear Implantation in Patients With Intracochlear and Intralabyrinthine Schwannomas.
    Carlson ML; Neff BA; Sladen DP; Link MJ; Driscoll CL
    Otol Neurotol; 2016 Jul; 37(6):647-53. PubMed ID: 27273407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug delivery in cochlear implantation.
    Dhanasingh A; Hochmair I
    Acta Otolaryngol; 2021 Mar; 141(sup1):135-156. PubMed ID: 33818265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Extracochlear Electrodes in Cochlear Implants with Electric Field Imaging/Transimpedance Measurements: A Human Cadaver Study.
    de Rijk SR; Tam YC; Carlyon RP; Bance ML
    Ear Hear; 2020; 41(5):1196-1207. PubMed ID: 31923041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracochlear PLGA based implants for dexamethasone release: Challenges and solutions.
    Lehner E; Gündel D; Liebau A; Plontke S; Mäder K
    Int J Pharm X; 2019 Dec; 1():100015. PubMed ID: 31517280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracochlear misdirected implantation of a cochlear implant.
    Tange RA; Grolman W; Maat A
    Acta Otolaryngol; 2006 Jun; 126(6):650-2. PubMed ID: 16720451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local inner ear application of dexamethasone in cochlear implant models is safe for auditory neurons and increases the neuroprotective effect of chronic electrical stimulation.
    Scheper V; Hessler R; Hütten M; Wilk M; Jolly C; Lenarz T; Paasche G
    PLoS One; 2017; 12(8):e0183820. PubMed ID: 28859106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of local application of insulin-like growth factor for prevention of inner-ear damage caused by electrode trauma.
    Gur H; Alimoglu Y; Duzenli U; Korkmaz S; Inan S; Olgun L
    J Laryngol Otol; 2017 Mar; 131(3):245-252. PubMed ID: 28124637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention.
    Ye Q; Tillein J; Hartmann R; Gstoettner W; Kiefer J
    Ear Hear; 2007 Jun; 28(3):361-9. PubMed ID: 17485985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra- and Intracochlear Electrocochleography in Cochlear Implant Recipients.
    Dalbert A; Pfiffner F; Röösli C; Thoele K; Sim JH; Gerig R; Huber AM
    Audiol Neurootol; 2015; 20(5):339-48. PubMed ID: 26340649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The progress of topical drug delivery to the inner ear for the inhibition of inflammation and fibrosis following cochlear implantation].
    Yu HR; Jia H; Yang J
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jan; 54(1):69-72. PubMed ID: 30704176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ear Cubes for local controlled drug delivery to the inner ear.
    Gehrke M; Sircoglou J; Gnansia D; Tourrel G; Willart JF; Danede F; Lacante E; Vincent C; Siepmann F; Siepmann J
    Int J Pharm; 2016 Jul; 509(1-2):85-94. PubMed ID: 27050866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inner Ear Pharmacotherapy for Residual Hearing Preservation in Cochlear Implant Surgery: A Systematic Review.
    Parys QA; Van Bulck P; Loos E; Verhaert N
    Biomolecules; 2022 Mar; 12(4):. PubMed ID: 35454118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracochlear Position of Cochlear Implants Determined Using CT Scanning versus Fitting Levels: Higher Threshold Levels at Basal Turn.
    van der Beek FB; Briaire JJ; van der Marel KS; Verbist BM; Frijns JH
    Audiol Neurootol; 2016; 21(1):54-67. PubMed ID: 26891130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cochlear implantation: strategies to protect the implanted cochlea from middle ear infection.
    Jackler RK; O'Donoghue GM; Schindler RA
    Ann Otol Rhinol Laryngol; 1986; 95(1 Pt 1):66-70. PubMed ID: 3753835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.